Skip to main content
Sign In
Linda Crnic Institute for Down Syndrome

 

CounterACT

PROGRAM'S GOAL

    Develop new therapeutic measures to enhance our medical response capabilities in the event of an emergency, specifically sulfur mustard poisoning resulting in acute lung and skin injury, as well as for chlorine gas inhalation injury. A long term goal of the Denver program is to attain FDA approval for the most effective countermeasures discovered.

RELATED LINKS

​​​​​​​​​​​​​​​

CounterACT Research Center

The National Institutes of Health (NIH) awarded our Center with a five-year renewal in 2010, which includes a $13 million grant to the University of Colorado Denver (with subcontracts to National Jewish Health and with an Interagency Agreement between NIH and United States Army Research Institute of Chemical Defense, Aberdeen, MD).

This Center of Excellence was developed to focus on toxic inhaled chemicals, with an emphasis on sulfur mustard toxicity in the lung and skin, and, more recently, to include effects of chlorine on cardiopulmonary function.

The long-term goal of the Center is to develop an effective treatment for mustard gas-induced injury in lung and skin to treat sulfur mustard poisoning, a potent chemical warfare vesicant, and to develop similarly effective rescue agents for chlorine gas inhalation. There is an increasing emphasis on the acute, life-threatening effects of these agents.

For more, visit our About Us​ page.

 
​​​​​​​​​​

CONTACT INFORMATION

Denver CounterACT Center of Excellence
Denver CounterACT
Pediatric Airways Research Center
12700 E. 19th Ave
Mailstop 8615
Room P15-4019
Aurora, CO 80045

Email:  Gabriele Cheatham
Phone: 303-724-0744
Fax:     303-724-7334


 
 
​​​​​​​​
​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​